Patent · US Active

Anti-FGFR3 antibodies and methods using same

US8410250B2 · kind B2 · utility

17Cited by
81References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2010
Grant dateApr 2, 2013
Priority date—
Expiry dateDec 26, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.